GlobeNewswire

Mitratech’s TAP Workflow Automation Gains Momentum with New Customers and Launches New Features at ACC EUROPE to Advance the Practice of Legal Operations

Del

New TAPSign Electronic Signature and Work Flow Sharing Enhance Document Management and Collaboration

SLOUGH, England, May 13, 2019 (GLOBE NEWSWIRE) -- Mitratech announced at ACC EUROPE 2019 today new capabilities and benefits for its rapidly growing community of customers using TAP Workflow Automation to innovate and automate legal processes. TAP was added to Mitratech’s proven portfolio of end-to-end solutions in April 2018. Over the past year, 26 new legal departments have selected TAP to extend services and operations across the enterprise.

Additionally, TAP now includes TAPSign electronic signature strengthening the management of documents and forms such as contracts, NDA’s retention letters, partner and supplier agreements, and virtually any other internal approval. TAPSign empowers clients to digitally accelerate business processes and comply with sustainability efforts to replace paper with digital forms and documents.

The latest TAP release also includes simple, one-click import and export capability for bringing in new workflow designs or sharing them out with others. With this capability in place, Mitratech also announced a new TAP Co-Innovation Center. Customers can go to the Co-Innovation Center to view the process automation ideas and use cases of their peers, and at their discretion, can now easily share workflows. This capability is a cornerstone to the overall theme of co-innovation between customers, employees and partners that permeates across the TAP ecosystem, and is transforming the legal operations community.

“Through Mitratech’s TAP Co-Innovation Center, we realize the opportunity to develop and share ideas on how we can use TAP to improve – if not eliminate – effort heavy, high volume/low risk business processes in our organization and between our Legal systems,” said Greg Bennett, senior manager, legal operations, Gilead Sciences. “More importantly, the Innovation Center provides a front-row seat to see how this technology is rapidly shaping a new landscape in the legal business.”

“Mitratech could not be more excited about the innovation we are seeing in the delivery of legal services across the legal operations and TAP community,” said Mitratech CEO Jason Parkman. “Our customers are creating true Legal Service Centers that improve outcomes by promoting innovation and excellence across not just the legal department, but the entire enterprise.”

At the ACC EUROPE 2019 conference, Mitratech’s Tim Wilson will present “The Rise of (Wearing the Glasses of) the Chief Legal Operations Officer” with Elisabeth De Dobbeleer, Vice President & Deputy General Counsel, EMEAR, Cisco Systems Belgium, Chris Fowler, General Counsel BT Technology and Transformation, British Telecom and Mo Zain Ajaz, Chief Operations Officer for Legal and General Counsel, National Grid. Mitratech invites anyone attending ACC EUROPE 2019 to join the session or stop by the Mitratech stand #18 to learn more about its solutions for legal operations.

ABOUT MITRATECH:
Mitratech is a proven global technology partner for corporate legal professionals who seek out and maximize opportunities to raise productivity, control expenses, and mitigate risk by deepening organizational alignment, increasing visibility, and spurring collaboration across the enterprise. Serving 1,200 organizations of all sizes across the globe, we represent almost 40 percent of the Fortune 500 and over 500,000 users in over 160 countries.

With Mitratech’s proven portfolio of end-to-end solutions, operational best practices spread throughout the enterprise, standardizing processes and accelerating time-to-value. By unlocking every opportunity to drive progress and improve outcomes, Mitratech is helping legal teams rise to the challenge of serving the evolving needs of the modern, dynamic enterprise. For more information, visit https://www.mitratech.com/.

MEDIA CONTACT:

Sue Huss
Mitratech
sue.huss@mitratech.com
619-379-4396

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Gainsight Unveils the Customer Cloud, the Future of Customer Success Technology23.5.2019 19:30:00 CESTPressemelding

New Products Announced at Pulse 2019 to Drive Customer Success Across the Enterprise SAN FRANCISCO, May 23, 2019 (GLOBE NEWSWIRE) -- Today, Gainsight® launched the Customer Cloud —a first-of-its-kind solution for subscription businesses looking to adopt a customer-centric philosophy that enables them to retain customers while also driving company growth post-sale. According to the 2018 Subscription Economy Index report, subscription companies are growing five times faster than S&P and retail sales. The Gainsight Customer Cloud caters to these businesses by combining the company’s Customer Success and Product Experience products with three new product innovations to offer a powerful set of solutions for businesses to optimize their subscription strategies through technology. “With the maturity of cloud technology and the subscription economy, customer expectations have drastically changed. Companies are struggling to leverage existing tools to satisfy the increasing demands of their cus

Lowered Return Expectations Among Several Trends Pointing to a Shift in Private Markets Due Diligence says New eVestment Survey23.5.2019 15:30:00 CESTPressemelding

ATLANTA, May 23, 2019 (GLOBE NEWSWIRE) -- Private markets funds have continued to rake in new commitments from institutional investors eager to diversify their portfolios and capture the returns private markets investments can offer. However, investors are now tempering their private markets return expectations. Coupled with other industry trends, this will have implications for private markets fundraising and due diligence according to a new eVestment report, produced in association with parent company Nasdaq. The 2019 eVestment Private Markets Due Diligence Survey of institutional investors, consultants and private markets fund managers finds that 52% of investors expect returns in the space to decline in the future (page 16). Only 12% of investors expected private equity returns to increase, with the balance – 36% – expecting returns to stay about the same. Forty-seven percent of investors surveyed expect to see lower returns in venture capital vs. just 16% of investors who expect r

Collibra Announces 2019 Excellence Awards Winners23.5.2019 15:00:00 CESTPressemelding

American Express, Deloitte, and Lloyds Banking Group recognized as leaders in harnessing data to drive digital transformation NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- Collibra, the leader in enterprise data governance and catalog software, today announced the winners of the 2019 Collibra Excellence Awards. Presented at the annual Data Citizens conference in New York, the awards honor teams and individuals driving innovative data strategy by collaborating with Collibra. “In today’s market, organizations that are able to maximize data have the power to transform entire industries,” said Felix Van de Maele, co-founder and CEO of Collibra. “We’re proud to honor the recipients of the Collibra Excellence Awards, a cutting-edge group at the forefront of data-driven innovation.” The 2019 Collibra Excellence Award Winners: American Express — Distinguished Data Program of the Year American Express was recognized for its data governance transformation, which began as a compliance initiative and

XBiotech Announces Plan to Launch Randomized Phase 2b Study of Bermekimab in Hidradenitis Suppurativa23.5.2019 14:20:00 CESTPressemelding

AUSTIN, Texas, May 23, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced plans to advance its dermatology program for its true human antibody bermekimab with the launch of a randomized, double-blind, placebo controlled, Phase 2b clinical study in patients with moderate to severe Hidradenitis Suppurativa (HS). This Phase 2b study will evaluate safety and efficacy of bermekimab at different subcutaneous doses compared with placebo. The study will further evaluate efficacy of bermekimab in HS and guide dosing strategies for the anticipated Phase 3 registration study. The Company expects the first patient to be enrolled during the third quarter of 2019. The Phase 2b study follows two previous successful clinical studies of bermekimab to treat HS. XBiotech recently evaluated bermekimab in a phase 2 study involving two groups of patients with HS: those who had no prior treatment with biologics; and those who had failed the only approved biological therapy to treat HS. The study, whi

LGC CAPITAL Announces Results of Annual Meeting, Appointment of New Chairman and Approval of Name Change to Elixxer Ltd.23.5.2019 14:00:00 CESTPressemelding

MONTRÉAL, May 23, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG) (OTCQB: LGGCF) ("LGC" or the “Corporation”) is pleased to announce the results of its annual and special meeting of shareholders (the “Meeting”) held yesterday in Montreal, Quebec. At the Meeting, all five of the nominees listed in the Corporation’s management information circular dated April 17, 2019 were elected as directors, all with a vote of more than 92% of the shares voted in their favour. Accordingly, the directors of LGC for the ensuing year are Mohammed Ghafari, Mazen Haddad, Rafi Hazan, David Lenigas and Ferras Zalt. At the Meeting, shareholders adopted a special resolution approving a change in the name of the Corporation to “Elixxer Ltd.” or such other name as the Corporation’s directors may determine. The special resolution was supported by 98.94% of the votes cast at the Meeting. The Corporation intends to proceed with the name change as expeditiously as possible. Shareholders also adopted: a special

Merus Announces 2019 Annual General Meeting of Shareholders23.5.2019 14:00:00 CESTPressemelding

UTRECHT, The Netherlands, May 23, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human bispecific antibody therapeutics, today announced that the 2019 Annual General Meeting of Shareholders will be held on June 12, 2019 at 1:00 pm (CEST) at the offices of NautaDutilh N.V. (address: Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands). All relevant documents and information for the meeting, including the notice and agenda, are available in the 'Investor Relations' section of Merus’ website (www.merus.nl) under “Financial Information”. About Merus N.V. Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics®, which are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical and clin